Literature DB >> 1373799

Role of NAD(P)H:(quinone acceptor) oxidoreductase (DT-diaphorase) in activation of mitomycin C under hypoxia.

A Begleiter1, E Robotham, M K Leith.   

Abstract

The role of the two-electron reducing enzyme DT-diaphorase in the activation of mitomycin C under hypoxic conditions was investigated. Mitomycin C activity was compared in L5178Y murine lymphoblasts, which have low levels of DT-diaphorase activity, and L5178Y/HBM10 cells, which have elevated levels of enzyme activity. The cytotoxic and DNA cross-linking activities of mitomycin C were greater in L5178Y/HBM10 cells than in L5178Y cells. In L5178Y/HBM10 cells, dicoumarol, an inhibitor of DT-diaphorase, decreased cell kill and DNA cross-linking by mitomycin C in air but had no significant effect on these activities under hypoxia. By comparison, in L5178Y cells, dicoumarol had no effect on drug activity under either aerobic or hypoxic conditions. A model for the activation of mitomycin C by both one-electron and two-electron reduction is proposed. Our findings suggest that two-electron reduction by DT-diaphorase has only a limited role in the activation of mitomycin C under hypoxic conditions, although this enzyme appears to be an important contributor to drug activation under aerobic conditions.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1373799

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  10 in total

1.  Differential toxicity of mitomycin C and porfiromycin to aerobic and hypoxic Chinese hamster ovary cells overexpressing human NADPH:cytochrome c (P-450) reductase.

Authors:  M F Belcourt; W F Hodnick; S Rockwell; A C Sartorelli
Journal:  Proc Natl Acad Sci U S A       Date:  1996-01-09       Impact factor: 11.205

Review 2.  DT-diaphorase in activation and detoxification of quinones. Bioreductive activation of mitomycin C.

Authors:  D Ross; D Siegel; H Beall; A S Prakash; R T Mulcahy; N W Gibson
Journal:  Cancer Metastasis Rev       Date:  1993-06       Impact factor: 9.264

Review 3.  NAD(P)H:quinone oxidoreductase 1 (NQO1) in the sensitivity and resistance to antitumor quinones.

Authors:  David Siegel; Chao Yan; David Ross
Journal:  Biochem Pharmacol       Date:  2011-12-24       Impact factor: 6.100

4.  Induction of DT-diaphorase by 1,2-dithiole-3-thiones in human tumour and normal cells and effect on anti-tumour activity of bioreductive agents.

Authors:  G P Doherty; M K Leith; X Wang; T J Curphey; A Begleiter
Journal:  Br J Cancer       Date:  1998-04       Impact factor: 7.640

5.  Transfection of COS-1 cells with DT-diaphorase cDNA: role of a base change at position 609.

Authors:  V Misra; H J Klamut; A M Rauth
Journal:  Br J Cancer       Date:  1998-04       Impact factor: 7.640

6.  NRF2: KEAPing Tumors Protected.

Authors:  Ray Pillai; Makiko Hayashi; Anastasia-Maria Zavitsanou; Thales Papagiannakopoulos
Journal:  Cancer Discov       Date:  2022-03-01       Impact factor: 38.272

7.  Enhanced cytotoxicity of mitomycin C in human tumour cells with inducers of DT-diaphorase.

Authors:  X Wang; G P Doherty; M K Leith; T J Curphey; A Begleiter
Journal:  Br J Cancer       Date:  1999-06       Impact factor: 7.640

Review 8.  Implications of NQO1 in cancer therapy.

Authors:  Eun-Taex Oh; Heon Joo Park
Journal:  BMB Rep       Date:  2015-11       Impact factor: 4.778

9.  Dietary induction of NQO1 increases the antitumour activity of mitomycin C in human colon tumours in vivo.

Authors:  A Begleiter; M K Leith; J A Thliveris; T Digby
Journal:  Br J Cancer       Date:  2004-10-18       Impact factor: 7.640

10.  Establishment and characterization of non-small cell lung cancer cell lines resistant to mitomycin C under aerobic conditions.

Authors:  K Shibata; K Kasahara; T Bando; Y Nakatsumi; M Fujimura; T Tsuruo; T Matsuda
Journal:  Jpn J Cancer Res       Date:  1995-05
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.